Complete deletion of the TET_JBP domain (ΔJBP) of TET2 in AML patients had a lower CR rate and shorter EFS and OS.263TET2I1762V acted as a favorable prognostic factor in AML.264TET2 SNP rs2454206 correlated with improved survival in childhood CN-AML.265TET2 exon 2 splicing status might improve survival in CN-AML patients.266TET2 mutations were reported to be associated with several clinical characteristics. This evidence concerns the gene TET2 and acute myeloid leukemia.